Display options
Cite
Wieczorek M, Abualrous ET, Sticht J, et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front Immunol. 2017;8:292doi: 10.3389/fimmu.2017.00292.
Wieczorek, M., Abualrous, E. T., Sticht, J., Álvaro-Benito, M., Stolzenberg, S., Noé, F., & Freund, C. (2017). Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Frontiers in immunology, 8292. https://doi.org/10.3389/fimmu.2017.00292
Wieczorek, Marek, et al. "Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation." Frontiers in immunology vol. 8 (2017): 292. doi: https://doi.org/10.3389/fimmu.2017.00292
Wieczorek M, Abualrous ET, Sticht J, Álvaro-Benito M, Stolzenberg S, Noé F, Freund C. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front Immunol. 2017 Mar 17;8:292. doi: 10.3389/fimmu.2017.00292. eCollection 2017. PMID: 28367149; PMCID: PMC5355494.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2017 Mar 17;8:292. doi: 10.3389/fimmu.2017.00292. eCollection 2017.

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.

Frontiers in immunology

Marek Wieczorek, Esam T Abualrous, Jana Sticht, Miguel Álvaro-Benito, Sebastian Stolzenberg, Frank Noé, Christian Freund

Affiliations

  1. Protein Biochemistry, Institute for Biochemistry, Freie Universität Berlin , Berlin , Germany.
  2. Computational Molecular Biology Group, Institute for Mathematics , Berlin , Germany.

PMID: 28367149 PMCID: PMC5355494 DOI: 10.3389/fimmu.2017.00292

Abstract

Antigen presentation by major histocompatibility complex (MHC) proteins is essential for adaptive immunity. Prior to presentation, peptides need to be generated from proteins that are either produced by the cell's own translational machinery or that are funneled into the endo-lysosomal vesicular system. The prolonged interaction between a T cell receptor and specific pMHC complexes, after an extensive search process in secondary lymphatic organs, eventually triggers T cells to proliferate and to mount a specific cellular immune response. Once processed, the peptide repertoire presented by MHC proteins largely depends on structural features of the binding groove of each particular MHC allelic variant. Additionally, two peptide editors-tapasin for class I and HLA-DM for class II-contribute to the shaping of the presented peptidome by favoring the binding of high-affinity antigens. Although there is a vast amount of biochemical and structural information, the mechanism of the catalyzed peptide exchange for MHC class I and class II proteins still remains controversial, and it is not well understood why certain MHC allelic variants are more susceptible to peptide editing than others. Recent studies predict a high impact of protein intermediate states on MHC allele-specific peptide presentation, which implies a profound influence of MHC dynamics on the phenomenon of immunodominance and the development of autoimmune diseases. Here, we review the recent literature that describe MHC class I and II dynamics from a theoretical and experimental point of view and we highlight the similarities between MHC class I and class II dynamics despite the distinct functions they fulfill in adaptive immunity.

Keywords: HLA; HLA-DM; adaptive immunity; antigen presentation; major histocompatibility complex; peptide exchange; protein dynamics; tapasin

References

  1. Nature. 1992 Nov 26;360(6402):364-6 - PubMed
  2. Nat Immunol. 2011 Jan;12(1):54-61 - PubMed
  3. Clin Cancer Res. 2014 Apr 1;20(7):1768-78 - PubMed
  4. PLoS One. 2008 Mar 19;3(3):e1814 - PubMed
  5. J Exp Med. 2000 Dec 18;192(12):1697-706 - PubMed
  6. Science. 1992 Dec 4;258(5088):1658-62 - PubMed
  7. J Immunol. 2003 Nov 15;171(10):5287-95 - PubMed
  8. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1534-8 - PubMed
  9. Nature. 1993 Jul 1;364(6432):33-9 - PubMed
  10. Clin Dev Immunol. 2013;2013:467852 - PubMed
  11. Eur J Immunol. 2010 Jan;40(1):214-24 - PubMed
  12. J Phys Chem B. 2008 May 15;112(19):6057-69 - PubMed
  13. J Biol Chem. 2007 Jul 20;282(29):21425-36 - PubMed
  14. Biopolymers. 2009 Jan;91(1):14-27 - PubMed
  15. PLoS Comput Biol. 2012;8(3):e1002404 - PubMed
  16. Nat Genet. 2012 Jan 29;44(3):291-6 - PubMed
  17. J Biol Chem. 2013 Aug 23;288(34):24372-81 - PubMed
  18. Biophys J. 2004 Oct;87(4):2203-14 - PubMed
  19. PLoS One. 2014 Feb 20;9(2):e89657 - PubMed
  20. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15050-5 - PubMed
  21. Curr Opin Immunol. 2014 Dec;31:24-30 - PubMed
  22. Nat Struct Mol Biol. 2013 Jan;20(1):90-8 - PubMed
  23. J Immunol. 2015 Nov 1;195(9):4503-13 - PubMed
  24. Immunity. 2000 Oct;13(4):517-27 - PubMed
  25. Immunity. 2009 Jan 16;30(1):21-32 - PubMed
  26. EMBO J. 2007 Mar 21;26(6):1681-90 - PubMed
  27. J Biol Chem. 2014 Aug 22;289(34):23449-64 - PubMed
  28. J Immunol. 2009 Oct 1;183(7):4187-91 - PubMed
  29. J Cell Sci. 2014 Jul 1;127(Pt 13):2885-97 - PubMed
  30. Sci Rep. 2015 Oct 20;5:14928 - PubMed
  31. Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19329-34 - PubMed
  32. Nat Immunol. 2003 Sep;4(9):913-9 - PubMed
  33. Chem Pharm Bull (Tokyo). 2003 Aug;51(8):923-8 - PubMed
  34. Mol Immunol. 2008 Aug;45(14):3714-22 - PubMed
  35. Mol Immunol. 2009 Apr;46(7):1304-11 - PubMed
  36. Science. 1996 Oct 25;274(5287):618-20 - PubMed
  37. Nat Struct Biol. 1998 May;5(5):377-84 - PubMed
  38. J Mol Biol. 2012 Oct 26;423(3):294-302 - PubMed
  39. J Immunol. 1999 Mar 15;162(6):3463-70 - PubMed
  40. Sci Rep. 2016 Jan 12;6:19085 - PubMed
  41. Eur J Immunol. 2016 Apr;46(4):834-45 - PubMed
  42. Mol Immunol. 2013 Sep;55(2):166-8 - PubMed
  43. J Mol Biol. 2012 Jan 13;415(2):429-42 - PubMed
  44. Mol Immunol. 2013 Oct;55(3-4):393-9 - PubMed
  45. Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9231-6 - PubMed
  46. J Biol Chem. 2013 Nov 8;288(45):32797-808 - PubMed
  47. Mol Immunol. 2009 May;46(8-9):1839-44 - PubMed
  48. Immunity. 2003 Aug;19(2):183-92 - PubMed
  49. Immunol Rev. 2005 Oct;207:100-11 - PubMed
  50. BMC Immunol. 2012 Aug 08;13:43 - PubMed
  51. J Biol Chem. 2006 May 5;281(18):12699-704 - PubMed
  52. J Immunol. 1999 Apr 1;162(7):4030-6 - PubMed
  53. Immunogenetics. 2013 Mar;65(3):157-72 - PubMed
  54. Tissue Antigens. 2010 Oct;76(4):259-75 - PubMed
  55. J Biol Chem. 2008 Jun 13;283(24):16840-9 - PubMed
  56. J Chem Theory Comput. 2015 Nov 10;11(11):5525-42 - PubMed
  57. FEBS J. 2011 May;278(10):1713-27 - PubMed
  58. Biochemistry. 1999 May 4;38(18):5878-87 - PubMed
  59. Biochemistry. 1998 Dec 15;37(50):17371-80 - PubMed
  60. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10978-83 - PubMed
  61. Nat Immunol. 2009 Oct;10(10):1096-101 - PubMed
  62. Curr Biol. 1998 Jun 4;8(12):717-20 - PubMed
  63. J Clin Immunol. 2004 Jul;24(4):462-70 - PubMed
  64. Proteins. 2011 Nov;79(11):3007-24 - PubMed
  65. PLoS One. 2012;7(3):e32865 - PubMed
  66. Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15383-8 - PubMed
  67. Immunity. 1997 Mar;6(3):293-302 - PubMed
  68. Science. 1992 Aug 14;257(5072):927-34 - PubMed
  69. Cell. 1990 Aug 10;62(3):563-7 - PubMed
  70. Curr Opin Immunol. 2015 Jun;34:9-15 - PubMed
  71. Biol Chem. 2004 Sep;385(9):763-78 - PubMed
  72. J Biol Chem. 2004 Jul 2;279(27):28197-201 - PubMed
  73. Immunol Rev. 2012 Nov;250(1):144-57 - PubMed
  74. J Biol Chem. 2005 Jun 24;280(25):23900-9 - PubMed
  75. Protein Expr Purif. 1999 Feb;15(1):105-14 - PubMed
  76. Biochemistry. 1998 Mar 3;37(9):3001-12 - PubMed
  77. Nat Immunol. 2007 Aug;8(8):864-72 - PubMed
  78. Mol Immunol. 2012 Jan;49(4):628-39 - PubMed
  79. Science. 1992 Mar 6;255(5049):1261-3 - PubMed
  80. Immunity. 1998 Nov;9(5):699-709 - PubMed
  81. Chem Pharm Bull (Tokyo). 2002 Sep;50(9):1209-14 - PubMed
  82. Nature. 1990 Jun 14;345(6276):615-8 - PubMed
  83. J Chem Phys. 2007 Apr 21;126(15):155102 - PubMed
  84. Int Immunol. 2001 Oct;13(10):1275-82 - PubMed
  85. J Mol Biol. 2008 Feb 22;376(3):798-810 - PubMed
  86. Eur J Immunol. 2013 Nov;43(11):3051-60 - PubMed
  87. Nature. 1992 Aug 27;358(6389):764-8 - PubMed
  88. Front Immunol. 2013 Aug 29;4:262 - PubMed
  89. FASEB J. 2011 Nov;25(11):3989-98 - PubMed
  90. Trends Immunol. 2008 Mar;29(3):141-7 - PubMed
  91. J Mol Biol. 1999 Feb 12;286(1):207-18 - PubMed
  92. FASEB J. 2012 Dec;26(12):5071-80 - PubMed
  93. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2495-500 - PubMed
  94. Science. 1994 Jul 15;265(5170):398-402 - PubMed
  95. J Mol Biol. 1996 Nov 15;263(5):627-36 - PubMed
  96. Mol Immunol. 2013 Jul;54(3-4):386-96 - PubMed
  97. PLoS One. 2015 Aug 13;10(8):e0135421 - PubMed
  98. Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):202-7 - PubMed
  99. J Immunol. 1999 Feb 1;162(3):1530-40 - PubMed
  100. J Biol Chem. 2014 Aug 29;289(35):24680-90 - PubMed
  101. Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1193-9 - PubMed
  102. J Immunol. 2003 Jan 15;170(2):961-8 - PubMed
  103. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12867-74 - PubMed
  104. Semin Immunol. 1993 Apr;5(2):75-80 - PubMed
  105. Protein Sci. 2007 Feb;16(2):299-308 - PubMed
  106. J Biomol NMR. 2013 Oct;57(2):167-78 - PubMed
  107. Haematologica. 2011 Jan;96(1):110-8 - PubMed
  108. Annu Rev Immunol. 1995;13:587-622 - PubMed
  109. Cell. 1993 Nov 19;75(4):693-708 - PubMed
  110. J Immunol. 1994 Mar 15;152(6):2874-81 - PubMed
  111. Biochemistry. 2005 Oct 25;44(42):13625-37 - PubMed
  112. J Immunol. 2012 Aug 1;189(3):1391-9 - PubMed
  113. PLoS One. 2008 Jun 11;3(6):e2403 - PubMed
  114. PLoS Comput Biol. 2011 Oct;7(10):e1002144 - PubMed
  115. J Immunol. 2015 Aug 1;195(3):1251-61 - PubMed
  116. PLoS One. 2011 Apr 14;6(4):e18662 - PubMed
  117. Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22219-24 - PubMed
  118. J Exp Med. 2011 Nov 21;208(12):2375-83 - PubMed
  119. J Biol Chem. 2015 Jan 30;290(5):2593-603 - PubMed
  120. Trends Immunol. 2001 Apr;22(4):194-9 - PubMed
  121. Nat Commun. 2016 Nov 09;7:13224 - PubMed
  122. Immunity. 1996 Mar;4(3):203-13 - PubMed
  123. Nature. 1994 Mar 17;368(6468):215-21 - PubMed
  124. Nature. 1991 May 23;351(6324):290-6 - PubMed
  125. J Immunol. 2005 Oct 15;175(8):4935-47 - PubMed
  126. J Biol Chem. 2006 Dec 15;281(50):38535-42 - PubMed
  127. Immunity. 2000 Aug;13(2):213-22 - PubMed
  128. J Chem Phys. 2011 May 7;134(17):174105 - PubMed
  129. Nature. 1997 Jun 5;387(6633):630-4 - PubMed
  130. PLoS One. 2013 Aug 19;8(8):e72575 - PubMed
  131. Immunity. 2002 Jan;16(1):99-109 - PubMed
  132. PLoS One. 2010 Jul 19;5(7):e11653 - PubMed
  133. J Biol Chem. 2004 Apr 16;279(16):16561-70 - PubMed
  134. Eur J Immunol. 2015 Apr;45(4):1248-57 - PubMed
  135. Mol Immunol. 2009 Jun;46(10):2054-63 - PubMed
  136. Cell. 2012 Dec 21;151(7):1557-68 - PubMed

Publication Types